MetLife stock overview following recent performance

MetLife (MET) shares have moved higher over the past month, with a return of about 14%, while the past 3 months show a smaller gain. This recent performance has drawn fresh attention to the insurer’s fundamentals.

At a share price of US$78.08, MetLife’s recent 1 month share price return of 13.82% and 7 day return of 5.68% suggest building momentum, while the 1 year total shareholder return of 10.82% sits alongside solid 3 and 5 year total returns.

If this kind of move has you thinking about where else capital could work harder, it might be worth scanning for opportunities in infrastructure that supports long term themes such as power reliability, including 31 power grid technology and infrastructure stocks

With revenue of US$77.1b, net income of US$3.2b and an indicated intrinsic value gap alongside a discount to analyst targets, the key question is whether MetLife is still mispriced or if the market is already pricing in future growth.

Most Popular Narrative: 12.3% Undervalued

The current MetLife share price of $78.08 sits below a widely followed fair value estimate of $89.06, which is based on detailed long term forecasts and an 8.0% discount rate.

Strategic expansion of asset light, fee generating businesses (like employee benefits, asset management, and longevity reinsurance), combined with disciplined capital management, supports higher return on equity and more consistent, less capital intensive earnings growth.

Want to understand what is driving that projected upside? The narrative leans heavily on revenue compounding, margin rebuild and a future earnings multiple that is more conservative than many peers.

Result: Fair Value of $89.06 (UNDERVALUED)

However, there are still watchpoints here, including pressure on investment yields and credit risk in commercial mortgage loans, which could challenge the upside case.

Another View: Earnings Multiple Paints a Different Picture

The earlier fair value estimate suggests upside, but the current pricing on earnings tells a more cautious story. MetLife trades on a P/E of 16x, which is higher than both the US Insurance industry average of 11.6x and an estimated fair ratio of 14.3x.

This kind of premium indicates that the market already prices in a stronger outlook than peers and the fair ratio imply. That, in turn, raises the risk of disappointment if results or sentiment soften even slightly.

Next Steps

Balancing potential upside with clear risks can feel uneasy, so move quickly to review the data for yourself and weigh both sides of the story using the 3 key rewards and 2 important warning signs

Looking for more investment ideas?

If this MetLife update has you thinking about what else might be worth your attention, now is the right time to widen your search with focused stock ideas.

• Target higher quality opportunities by checking companies that look attractively priced on key fundamentals through the 59 high quality undervalued stocks.
• Build a steadier income stream by scanning for reliable payers in the 11 dividend fortresses.
• Cut down on unnecessary risk by focusing on companies highlighted in the 70 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.